news
Latest news
DYADIC INTERNATIONAL LAUNCHES FIBREZYME® G5000 HIGH PERFORMANCE POWDER PULP AND PAPER ENZYME
FIBREZYME® G5000 reduces production costs while also improving fiber-to-fiber bonding and pulp refining properties
JUPITER, Fla., March 14, 2012 - Dyadic International, Inc. announced that it will launch FibreZyme® G5000, a next generation, high performance powder enzyme designed to improve paper quality and improve the economics of various pulp and paper manufacturing processes, in Booth #1065 at the Tissue World Americas conference and exhibition being held at.
Thomas O’Shaughnessy, Vice President Sales & Marketing stated, “FibreZyme® G5000 is a great addition to our current FibreZyme® series of products and provides further evidence of the value-adding capabilities of Dyadic’s C1 platform technology. FibreZyme® G5000 operates under wide pH and temperature ranges allowing for seamless integration into most pulp and paper manufacturing processes.”
Specific attributes of FibreZyme® G5000 include the following:
• Reduces fiber raw material costs and petroleum-derived chemical usages
• Reduces pulp refining energy requirements
• Increases paper machine production rates and efficiencies
• Improves softness in tissue production
• Enhances pulp drainage rates and reduces paper drying demand
• Enhances and restores fiber strength and increases inter-fiber bonding through fibrillation
press releases
- Dyadic launches Fibrezyme G5000 (March 14, '12)
- Dyadic international partners with leading provider of nutritional ingredient solutions for production
of foof enzymes (February 29, '12) - Dyadic enters into research and license agreement with major
player in the animal and feed industry (June 27, '11) - Dyadic Netherlands enters into R&D collaboration with Sanofi Pasteur
and EngenBio (May 2, 2011) - Two new US patents issued to
Dyadic International (April 7, '11) - Dyadic International launches high performance enzyme for pulp and paper industry using new C1 production platform
(February 22, '11) - Dyadic International Signs Term Sheet for Potential Exclusive Outlicense of C1 Technology for Biopharmaceutical Applications
(June 9th '10) - Dyadic International Reports 2010 First Quarter Financial Results
(May 14th '10) - Dyadic International Extends Collaboration With The Scripps Research Institute
(December 14th '09) - Dyadic Netherlands Joins Kluyver Centre's Industrial Platform (November 10th '09)
- Dyadic Int. completes FDA gras notification process for C1-derived cellulase enzymes
(October 1st 2009) - Settlement with securities and exchange commission
(June 5th 2009)
